NFE2L2 and amyotrophic lateral sclerosis: These authors also demonstrated that the elimination of Nrf2 only affected NQO1, among different Nrf2-regulated phase II enzymes, leaving it an open question whether Nrf2-mediated neuroprotection is a key mechanism to prevent ALS neurodegeneration [168].